Ono Pharmaceutical Co., Ltd. (OPHLY)
OTCMKTS · Delayed Price · Currency is USD
5.50
+0.04 (0.82%)
At close: Feb 11, 2026
Ono Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 62,404 | 59,328 | 163,734 | 143,532 | 105,025 | 100,890 |
Depreciation & Amortization | 36,873 | 26,894 | 18,140 | 17,451 | 17,721 | 15,820 |
Loss (Gain) From Sale of Assets | - | 7,981 | 14,885 | 1,498 | 3,404 | 2,307 |
Other Operating Activities | -7,737 | -45,211 | -57,338 | -6,655 | -34,284 | -34,057 |
Change in Accounts Receivable | 3,042 | 7,391 | -19,782 | -14,513 | -15,283 | -7,179 |
Change in Inventory | 10,982 | 12,435 | -3,420 | -2,945 | -2,464 | -6,107 |
Change in Accounts Payable | 2,126 | 18,786 | -5,734 | 18,654 | 8,177 | 6,361 |
Change in Other Net Operating Assets | 13,474 | -5,145 | 175 | 2,588 | -20,467 | -4,058 |
Operating Cash Flow | 125,635 | 82,459 | 110,660 | 159,610 | 61,829 | 73,977 |
Operating Cash Flow Growth | 35.64% | -25.48% | -30.67% | 158.15% | -16.42% | -0.24% |
Capital Expenditures | -6,369 | -5,431 | -4,020 | -5,340 | -5,497 | -7,018 |
Sale of Property, Plant & Equipment | 15 | 9 | 903 | 6 | 14 | 2 |
Cash Acquisitions | - | -364,816 | - | - | - | - |
Sale (Purchase) of Intangibles | -47,150 | -2,559 | -16,809 | -9,157 | -6,780 | -13,275 |
Investment in Securities | 25,681 | 236,764 | 69,290 | -84,731 | 19,969 | -36,866 |
Other Investing Activities | -898 | -752 | -1,287 | -1,037 | -1,668 | -429 |
Investing Cash Flow | -28,721 | -136,785 | 48,077 | -100,259 | 6,038 | -57,586 |
Long-Term Debt Issued | - | 150,000 | - | - | - | - |
Total Debt Issued | 1,642 | 150,000 | - | - | - | - |
Long-Term Debt Repaid | - | -15,000 | - | - | - | - |
Total Debt Repaid | -33,338 | -15,000 | - | - | - | - |
Net Debt Issued (Repaid) | -31,696 | 135,000 | - | - | - | - |
Repurchase of Common Stock | -1 | -1 | -50,010 | -1 | -30,007 | -3 |
Common Dividends Paid | -37,423 | -37,516 | -37,183 | -29,742 | -27,666 | -22,449 |
Other Financing Activities | -7 | -3,184 | -2,655 | -2,741 | -2,564 | -2,302 |
Financing Cash Flow | -69,127 | 94,299 | -89,848 | -32,484 | -60,237 | -24,754 |
Foreign Exchange Rate Adjustments | -387 | -1,548 | 1,116 | 155 | 436 | 403 |
Miscellaneous Cash Flow Adjustments | 3 | 1 | - | 1 | 1 | - |
Net Cash Flow | 27,403 | 38,426 | 70,005 | 27,023 | 8,067 | -7,960 |
Free Cash Flow | 119,266 | 77,028 | 106,640 | 154,270 | 56,332 | 66,959 |
Free Cash Flow Growth | 35.74% | -27.77% | -30.87% | 173.86% | -15.87% | 0.41% |
Free Cash Flow Margin | 23.42% | 15.82% | 21.21% | 34.50% | 15.59% | 21.65% |
Free Cash Flow Per Share | 253.85 | 163.97 | 222.15 | 315.90 | 113.45 | 134.13 |
Cash Interest Paid | 2,160 | 1,408 | 92 | 74 | 70 | 73 |
Cash Income Tax Paid | 16,254 | 44,060 | 56,431 | 6,637 | 34,293 | 34,060 |
Levered Free Cash Flow | - | 71,819 | 79,783 | 116,639 | 18,091 | 31,716 |
Unlevered Free Cash Flow | - | 72,725 | 79,861 | 116,694 | 18,143 | 31,782 |
Change in Working Capital | 29,624 | 33,467 | -28,761 | 3,784 | -30,037 | -10,983 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.